OptiBiotix Health plc (OPTI) Ord 2p
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
No change
n/a
n/a
133.00p
£69.63 million
81.50p
n/a
58.50p
33.54
1.50p (1.88%) Previous:
1.50p
n/a
n/a
10,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/11/2017 | 30/11/2016 |
|---|---|---|
| Revenue (£m) | 0.19 | 0.29 |
| Profit before tax (£m) | 1.69 | (1.52) |
| Adjusted EPS (p): | 2.43 | (1.67) |
| P/E ratio | 28.40 | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
OptiBiotix partner gets approval to make SlimBiome in India
11 April 2019 11:16
-
OptiBiotix inks deal with DKSH for Italy and Spain markets
20 March 2019 07:41
-
Optibiotix Health expands international reach through supply agreement
15 March 2019 08:16
-
SlimBiome® receives approval from FSSAI in India
11 April 2019 07:00
-
SlimBiome® Medical agreement for Bulgaria
9 April 2019 07:00
-
Grant of Options
27 March 2019 15:18
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.